Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Other Non-Current Liabilities (2018 - 2019)

Black Diamond Therapeutics' Other Non-Current Liabilities history spans 2 years, with the latest figure at $16000.0 for Q4 2019.

  • For Q4 2019, Other Non-Current Liabilities fell 99.6% year-over-year to $16000.0; the TTM value through Dec 2019 reached $16000.0, down 99.6%, while the annual FY2019 figure was $16000.0, 99.6% down from the prior year.
  • Other Non-Current Liabilities reached $16000.0 in Q4 2019 per BDTX's latest filing, down from $4.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $4.0 million in Q4 2018 to a low of $16000.0 in Q4 2019.